TG Therapeutics | TGTX - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
AbbVie USD 12.54B 474M 2026-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.89B 415M 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Bayer EUR 6.94B 1.58B 2025-12
Biogen USD 1.82B 169.5M 2026-03
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Curis USD 1.14M 8.86M 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
J&J USD 17.24B 642M 2026-03
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Novartis USD 10.07B 184M 2026-03
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
TG Therapeutics USD 171.41M 16.98M 2026-03
Verastem USD 14.64M 14.1M 2025-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03